Former buy-side analyst. Leads the desk with a focus on global markets, macro flows and what moves portfolios.

Novo Nordisk heads into Monday facing investor pressure to outline a growth plan beyond Wegovy. With semaglutide patents expiring early next

Oil prices slipped to a more-than-a-week low on hopes that diplomacy over Iran's conflict could ease supply fears, while chipmakers rallied

Red Avenue New Materials Group has launched a Hong Kong IPO, aiming to raise up to HK$3 billion. Shares are being marketed at HK$39-HK$44, w

Catalyst Metals has revealed a much larger gold resource at its Cinnamon deposit in Western Australia, up 370% to 541,000 ounces. The upgrad

The yen steadied near 156.64 per dollar after a rough week, as traders watched for possible Tokyo intervention. The Bank of Japan's rate hik

Ramelius Resources has raised its fiscal 2030 gold production target to 560,000-610,000 ounces and increased spending on its Mt Magnet plant

Vietnam has been added to FTSE Russell's emerging markets indexes, a milestone that could attract billions in passive investment. The phased

Australia's Telix Pharmaceuticals is acquiring Germany's ITM for about $1.65 billion, with up to $700 million tied to the approval and sales

Hong Kong is pushing to grow its dim sum bond market, with yuan-denominated issuance reaching about 350 billion yuan in the first half. Offi

China's memory chipmaker CXMT says it has begun mass-producing its fifth-generation DRAM, built on an 11.95-nanometer platform. The new proc

Nippon Life, one of Japan's largest insurers, is preparing 2 trillion yen ($12.75 billion) for project-finance loans tied to infrastructure,

Traditional diversifiers like value stocks and small caps are increasingly moving with tech and AI. Here's how global infrastructure can hel